DCGI approves market authorisation for SII’s Covid vaccine Covovax as heterologous booster dose

New Delhi: The Drug Controller General of India (DCGI) has approved market authorisation to COVID-19 vaccine Covovax as a heterologous booster dose for adults who have been administered two doses of Covishield or Covaxin, official sources said Monday. The DCGI’s approval came following recommendations by the Subject Expert Committee of Continue Reading